Physician

Ali Daftarian, M.D.

According to 2025 Medicare claims, Ali Daftarian, M.D. (NPI: 1407018021) practices pain management in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is BRAZOS VALLEY PHYSICIANS ORGANIZATION,MSO-LLC (NPI: 1366299539; TIN: 742862145) and primary practice location at 77802-3487. Daftarian is affiliated with the CommonSpirit ACO I (ACO ID: A2164), participating under the MSSP model.

Daftarian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 481 traditional Medicare patients, billed 1,870 HCPCS/CPT codes, and received $136,442 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 3,461 prescription claims across 648 beneficiaries totaling $168,968 in drug costs, led by Belbuca (Buprenorphine Hcl). 2018 DME data shows 12 claims. Open Payments data shows 24 records totaling $2,942. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $509,620 to $136,442. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	790	7,162	$509,620
2016	568	3,428	$232,341
2017	550	6,072	$532,261
2018	562	3,560	$276,663
2019	494	2,768	$208,624
2020	380	2,263	$175,983
2021	391	2,059	$173,240
2022	405	2,037	$172,673
2023	404	1,909	$166,944
2024	481	1,870	$136,442

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	668	4,012	$314,561
2016	553	2,759	$252,052
2017	487	2,473	$211,681
2018	515	2,789	$245,574
2019	502	3,129	$241,511
2020	513	3,342	$229,513
2021	509	3,564	$236,186
2022	578	3,659	$233,867
2023	564	3,775	$224,896
2024	648	3,461	$168,968

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$241
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	195	291	$94
62321	Injection of substance into middle or upper spine canal using imaging guidance	66	89	$75
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	283	468	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	62	66	$49
64484	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level	107	148	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belbuca	Buprenorphine Hcl	55	1,620	$53,452
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,264	30,443	$30,334
Fentanyl	Fentanyl	127	3,748	$11,885
Movantik	Naloxegol Oxalate	17	750	$9,821
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	215	5,566	$7,128

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$2,942	Stryker Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Daftarian, M.D.?

Tedicare shows public-source Medicare data for Ali Daftarian, M.D. (NPI 1407018021), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Daftarian, M.D. have ACO affiliation data?

Ali Daftarian, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164).

What billing organization is linked to Ali Daftarian, M.D.?

Ali Daftarian, M.D. is linked to BRAZOS VALLEY PHYSICIANS ORGANIZATION,MSO-LLC (billing NPI 1366299539) in the available physician profile data.

Does Ali Daftarian, M.D. have Open Payments data?

Ali Daftarian, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.